Screener
Pacira BioSciences, Inc. PCRX Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $205.88M-31.5% | $144.31M-49.1% | $158.55M-42.7% | $147.59M-40.0% | $300.48M+21.6% | ||
| $45.16M-68.9% | $57.87M-72.4% | $79.88M-61.6% | $98.75M-52.5% | $145.38M-7.5% | ||
| $132.42M+15.8% | $125.64M+19.9% | $124.07M+9.5% | $115.27M+14.5% | $114.37M+9.2% | ||
| $134.58M-9.2% | $150.37M+12.4% | $152.86M+22.0% | $157.68M+41.0% | $148.16M+43.2% | ||
| $615.22M-17.5% | $514.96M-32.2% | $547.97M-26.5% | $562.75M-18.4% | $745.61M+17.9% | ||
| $130.28M-16.0% | $136.28M-17.1% | $140.69M-15.8% | $147.39M-11.7% | $155.18M-8.1% | ||
| $19.64M-3.2% | $19.77M-8.1% | $20.21M— | $20.32M— | $20.3M-87.6% | ||
| —— | $319.49M-15.2% | $333.82M-21.6% | $348.14M-14.1% | $362.46M-13.6% | ||
| $1.24B-19.1% | $1.21B-23.8% | $1.26B-18.6% | $1.3B-14.7% | $1.54B-6.7% | ||
| $17.51M-41.9% | $14.01M-39.5% | $15.15M-20.8% | $17.69M-8.7% | $30.12M+60.8% | ||
| $122.01M-61.0% | $108.79M-65.4% | $120.59M-61.1% | $107.08M-65.1% | $313.16M+238% | ||
| $363.12M+271% | $367.66M+262% | $372.19M+257% | $376.72M+252% | $97.83M-10.9% | ||
| $572M-26.6% | $554.64M-29.6% | $571.81M-26.2% | $570.36M-26.1% | $779.5M+1.6% | ||
| 250M0.0% | 250M0.0% | 250M+531,815% | 250M0.0% | 250M0.0% | ||
| -$191.75M+7.1% | -$196.41M+2.5% | -$199.32M+3.4% | -$200.96M+9.6% | -$206.39M-161% | ||
| $671.98M-11.3% | $653.89M-18.1% | $693.11M-11.0% | $727.21M-3.0% | $757.77M-13.8% | ||
| $1.24B-19.1% | $1.21B-23.8% | $1.26B-18.6% | $1.3B-14.7% | $1.54B-6.7% |
FAQ
- What are Pacira BioSciences, Inc.'s total assets?
- Pacira BioSciences, Inc. (PCRX) holds $1.2B in total assets, down 19.1% year over year.
- How much debt does Pacira BioSciences, Inc. have?
- Pacira BioSciences, Inc. carries $412.1M in total debt against $672.0M of shareholders' equity, a debt-to-equity ratio of 0.61.
- How much cash does Pacira BioSciences, Inc. have?
- Pacira BioSciences, Inc. holds $205.9M in cash and equivalents.
- Can Pacira BioSciences, Inc. cover its short-term obligations?
- Its current ratio is 5.04 — current assets exceed current liabilities.
- Where does Pacira BioSciences, Inc.'s balance sheet data come from?
- Every line is extracted from Pacira BioSciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
